Stock Earnings

Question 1

How did ALPMF's recent EPS compare to expectations?

Accepted Answer

The most recent EPS for Astellas Pharma Inc is $44.22, beating expectations of $29.14.

Question 2

How did Astellas Pharma Inc ALPMF's revenue perform in the last quarter?

Accepted Answer

Astellas Pharma Inc revenue for the last quarter is $44.22

Question 3

What is the revenue estimate for Astellas Pharma Inc?

Accepted Answer

According to 6 of Wall street analyst, the revenue estimate of Astellas Pharma Inc range from $578.02B to $503.66B

Question 4

What's the earning quality score for Astellas Pharma Inc?

Accepted Answer

Astellas Pharma Inc has a earning quality score of /. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.

Question 5

When does Astellas Pharma Inc report earnings?

Accepted Answer

Astellas Pharma Inc next earnings report is expected in 2026-01-28

Question 6

What are Astellas Pharma Inc's expected earnings?

Accepted Answer

Astellas Pharma Inc expected earnings is $480.78B, according to wall-street analysts.

Question 7

Did Astellas Pharma Inc beat earnings expectations?

Accepted Answer

Astellas Pharma Inc recent earnings of $524.32B beat expectations.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	$29.14	$44.22	+51.75%	BEAT
Q1 '26	$20.22	$38.21	+88.97%	BEAT
Q4 '25	$26.37	$41.84	+58.66%	BEAT
Q3 '25	$19.95	$-54.55	-373.43%	MISSED
Q2 '25	$16.12	$20.05	+24.37%	BEAT

Astellas Pharma Inc (ALPMF) Price

ALPMF Stock Price Chart

Latest Earnings Results: Q2 '26

Historical Earnings

Earnings FAQ